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In 2009, there were more than 194,000 new cases of breast cancer, and more than 40,000 deaths 
caused by this most common form of cancer among 
women in the United States.
Human epidermal growth factor receptor-2 
(HER2) positive breast cancer is one of the more 
aggressive forms of breast cancer and is prevalent  
in about one of every three cases of breast cancer. 
This protein is made in low levels by normal breast 
cells, but is produced in excessively high levels in 
HER2-positive breast cancer.  In addition, HER2-
positive tumors grow faster, recur more often than 
other breast tumors and are less responsive to 
hormone treatments. 
Wayne State University in conjunction with the 
Barbara Ann Karmanos Cancer Institute is on the 
cusp of a new discovery that may someday save 
many lives. Wei-Zen Wei, professor of immunology 
and microbiology in the School of Medicine and 
at Karmanos, is leading a research team that has 
developed a cancer vaccine that recognizes HER-2 
positive cancer cells, and helps to prevent their 
spread and destroy them. 
Currently being tested on tumor cells of  
mice that no longer responded to other HER2 
treatments, results to date have been remarkable, 
with the vaccine preventing further growth and 
eliminating toxicity that often occurs with other 
forms of treatment.
The power in the DNA vaccine is its ability to 
stimulate a patient’s immune system to prevent  
the disease. 
“We each have an immune system to help fight 
off disease,” explained Wei. “However, when 
cancer develops, the immune system can’t always 
distinguish tumor cells from normal cells, so the full 
power of the immune system is not harnessed to 
fight the disease. This vaccine helps to educate the 
immune system so that it recognizes HER2-positive 
cancer cells, helps destroy them and prevents them 
from spreading.” 
The vaccine consists of “naked” DNA – genes that 
code for the HER2 receptor – as well as an immune 
stimulant. The researchers used pulses of electricity 
to deliver the injected vaccine into leg muscles in 
mice, where the gene produced a huge quantity of 
HER2 receptors that activated both antibodies and 
killer T cells. 
“While HER2 receptors are not usually seen by 
the immune system when they are expressed at 
low levels on the surface of normal cells, a sudden 
flood of receptors alerts the body to an invasion 
that needs to be eliminated,” said Wei. “During that 
process, the immune system learns to attack cancer 
cells that display large numbers of these receptors.”
“Both tumor cells that respond to current targeted 
therapies and those that are resistant to these 
treatments were eradicated,” said Wei. 
“The incredible efforts of Wei and her research 
team are bringing us closer to new answers for 
patients with HER2 tumors that are resistant to 
current treatments available,” said Gloria Heppner, 
associate vice president for research at WSU. “One 
day soon I hope we will be entering human clinical 
trials, ultimately putting us one step closer to 
eliminating breast cancer.”
For more information, visit:  
http://www.med.wayne.edu/immunology/Pages/
Faculty_Web_Pages/wei.html
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About Dr. WEI-ZEN WEI:
Dr. Wei-Zen Wei received her B.S. in plant pathology 
from National Taiwan University, her M.S. in medical 
microbiology from State University of New York and a 
Ph.D. in biology from Brown University. She joined the 
Karmanos Cancer Institute in 1983 and Wayne State 
University in 1994.
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